Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

HealthDay News — Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online January 27 in Circulation.

Grafting patches of lab-grown muscle to the surface of the heart could offer a lifeline for people waiting for a transplant.

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

The clinical chemistry test is intended to help diagnose heart failure using the N-terminal pro b-type natriuretic peptide biomarker.

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

Heart disease remains the top global killer. Learn about its impact on health, key risk factors, and approaches to prevention ...

Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...

Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...

Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...